Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.36
-0.03 (-2.16%)
At close: Aug 15, 2025, 3:59 PM
1.38
1.10%
After-hours: Aug 15, 2025, 05:51 PM EDT
Acrivon Therapeutics Common Stock Fail-to-Deliver
Total FTD Shares
19.42K
Below Average
FTD / Avg. Volume
4.46%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jun 27, 2025,
Acrivon Therapeutics Inc. Common Stock has
19,417
shares failed to deliver, representing 4.46%
of the average daily volume of
435,708
shares. Over the past year, the monthly average FTD is
2,747
shares, with the current level 607% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jun 27, 2025 | 1.2 | 19.42K | +32.48% |
May 27, 2025 | 1.1 | 14.66K | +1614.15% |
Apr 29, 2025 | 1.44 | 855 | +28.57% |
Mar 31, 2025 | 2.03 | 665 | +10983.33% |
Feb 25, 2025 | 5.53 | 6 | -99.36% |
Jan 28, 2025 | 5.55 | 940 | +41.78% |
Dec 23, 2024 | 6.36 | 663 | +149.25% |
Nov 26, 2024 | 7.35 | 266 | +285.51% |
Oct 30, 2024 | 8.35 | 69 | -97.72% |
Sep 20, 2024 | 7.47 | 3.03K | -89.84% |
Aug 30, 2024 | 9.49 | 29.82K | +33035.56% |
Jul 23, 2024 | 7.59 | 90 | -81.48% |
Jun 25, 2024 | 6.06 | 486 | -98.13% |
May 29, 2024 | 7.5 | 25.94K | +707.63% |
Apr 29, 2024 | 10 | 3.21K | +86.96% |
Mar 26, 2024 | 6.33 | 1.72K | -81.31% |
Feb 28, 2024 | 4.47 | 9.19K | +7196.03% |
Jan 23, 2024 | 4.25 | 126 | -98.01% |
Dec 26, 2023 | 5 | 6.33K | +63170.00% |
Nov 14, 2023 | 5.08 | 10 | -99.78% |
Oct 30, 2023 | 5.19 | 4.45K | +747.62% |
Sep 29, 2023 | 9.56 | 525 | -80.17% |
Aug 14, 2023 | 12.01 | 2.65K | +1790.71% |
Jul 24, 2023 | 12.36 | 140 | -82.89% |
Jun 29, 2023 | 13.32 | 818 | +19.59% |
May 31, 2023 | 11.78 | 684 | -40.93% |
Apr 28, 2023 | 12.31 | 1.16K | +168.68% |
Mar 31, 2023 | 12.69 | 431 | -70.34% |
Feb 15, 2023 | 22.5 | 1.45K | +591.90% |
Jan 31, 2023 | 16.2 | 210 | n/a |